September 14, 2017
August 25, 2017
“The survival of our species has always depended on advances in agriculture.” So begins the narration for Food Evolution, a new documentary about genetically modified foods and the high-stakes global controversy over their use.
Astrophysicist and popular science educator Neil deGrasse Tyson provides the soothing, even-handed voice that takes viewers from a plant genetics lab in the United States to a banana farm in Uganda, showing viewers how genetic modification works and the very real problems around the world it is helping to solve.
March 14, 2017
February 7, 2017
Hans Rosling, the Swedish doctor and professor who saved countless lives in the world’s poorest countries (and gave TED talks), has died of pancreatic cancer. In December, Nature had an interesting feature with him, discussing his life’s work.
Rosling was an antidote to uninformed pessimism. As Nature...
January 30, 2017votes Wednesday on President Trump’s...
January 18, 2017
December 15, 2016life expectancy fell in 2015, the most recent year for which data is available. Female life expectancy dropped from...
December 8, 2016
All legislative Powers herein granted shall be vested in a Congress of the United States, which shall consist of a Senate and House of Representatives.
The Framers of the Constitution...
November 28, 2016
This week on RealClear Radio Hour, Drs. Debra Patt and Kerry Emanuel discuss the politics of cancer care, chaos theory, and climate science.
We open the show with Dr. Debra Patt, practicing oncologist and Vice President of Texas Oncology. Debra explains how the well-intentioned federal 340B Drug Discount Program is actually driving up cancer care costs. With preferred vendor hospitals applying their 30-50% drug discounts to all patients, not just the underserved, industry-wide prices are being forced up to subsidize the program. On the whole, however, she is optimistic about the diagnostic innovations, therapeutic success, and a drastic drop in cancer mortality rates.
November 24, 2016
We have arrived at another divisive debate about the future of Americans’ access to health insurance and health care services and our ability to protect it. And no one can claim that the recent election provided a mandate for a specific path forward. With the flood of news about 2017 exchange pricing and Republicans working on how they can make good on their vows to repeal and replace the Affordable Care Act (ACA), now is a good time to examine “what might have been” in light of “what is” regarding our nation’s health care insurance and delivery system.
The reality is unspeakably ugly—skyrocketing premiums, disappearing competition, enormous unbudgeted federal spending on the exchanges, and unappreciated second-order effects like large increases on the group market (where most people obtain health care coverage) and rising small employer costs. These rising costs depress...